stockrowPrestige Consumer Healthcare Inc. (PBH) vs Regencell Bioscience Holdings Limited (RGC)
- Prestige Consumer Healthcare Inc. PBH 41.99 −5.26%
- Regencell Bioscience Holdings Limited RGC 5.20 −1.33%
Prestige Consumer Healthcare Inc. and Regencell Bioscience Holdings Limited are both Drug Manufacturers Specialty & Generic companies. Regencell Bioscience Holdings Limited is the larger, with a market value of $2.6B against $2.1B — 1.2× the size. Regencell Bioscience Holdings Limited has negative trailing earnings, so its P/E is not meaningful; Prestige Consumer Healthcare Inc. trades at 13.7×. Prestige Consumer Healthcare Inc. has the higher net margin (13.3% vs 0.00%) and the higher return on invested capital (9.59% vs 0.00%). Across the 12 metrics below, Prestige Consumer Healthcare Inc. leads on 9 and Regencell Bioscience Holdings Limited on 3.
Valuation
Profitability
| Metric | PBH | RGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 52.47% | — | 53.51% |
| Operating margin | 24.95% | — | 0.00% |
| Net margin | 13.29% | 0.00% | (2.45%) |
| Free cash flow margin | 18.35% | 0.00% | 0.00% |
| Return on equity | 8.23% | 0.00% | (0.80%) |
| Return on assets | 3.80% | 0.00% | (1.67%) |
| Return on invested capital | 9.59% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack